SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WMG who wrote (3126)12/4/1997 12:01:00 AM
From: JOHN W.  Read Replies (1) of 6136
 
Subject: Earnings
Date: Wed, Dec 3, 1997 09:49 EST
From: Rtboch
Message-id: <19971203145000.JAA23192@ladder01.news.aol.com>

I did a little checking and things don't look as bad as they did yersterday, they never or almost never do. It looks like the roche decision was not one sided and AGPH was not as pleased with roche's approach as it appeared. They wanted to pick and chose which drug to sponser and AGPH can fund its own research now so they agreed to disagree. Also if earnings come out on the low side of the esitmates the PE still looks great. If the bad news is
out (if) it seems reasonable to see 57 to 58 in six to nine months. The company needs to learn how to time its anouncements.

Robert

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext